Thursday, November 12, 2026

Dollar Rebounds From 2022 Lows as Pound Hits $1.3086 on UK Budget Fears

The dollar recovered from its lowest level since 2022 as the British pound fell to $1.3086 ahead of Chancellor Rachel Reeves' November 26 budget. UK 30-year gilt yields reached 5.21%, the highest since 1998, while global currency markets face uncertainty from Fed leadership transition and geopolitical tensions.

ViaNews Editorial Team

February 26, 2026

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
Dollar Rebounds From 2022 Lows as Pound Hits $1.3086 on UK Budget Fears
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The dollar rebounded Tuesday after hitting its lowest level since 2022, while the British pound dropped 0.5% to $1.3086 on mounting fiscal concerns ahead of the UK's November 26 budget.

Sterling fell to €1.13 against the euro—its weakest since April 2023—as UK 30-year gilt yields climbed to 5.21%, the highest in 26 years. Chancellor Rachel Reeves faces pressure to balance spending commitments with market stability.

"GBP remains under pressure from fiscal instability concerns," said Simon Phillips at No1 Currency. Mizuho Bank's Jordan Rochester warned the pound could break below $1.30 if budget measures disappoint markets.

Global currency volatility is rising as traders navigate dual uncertainties: the Fed chair replacement scheduled for June 2026 and shifting geopolitical risks. Iran-US nuclear talks pushed WTI crude up 1.5% to $61 per barrel Tuesday, affecting commodity-linked currencies worldwide.

The UK gilt market showed unexpected strength despite fiscal concerns. A recent auction drew £69 billion in bids for £4.25 billion of inflation-linked bonds, exceeding March's £67.5 billion record. About 25% of UK gilts are inflation-linked, compared to 10% in the US and France, making sterling more sensitive to inflation shifts.

"There's no sign bond markets are rattled," said Julian Jessop at the Institute of Economic Affairs. Mike Riddell at Fidelity noted gilts have been "the top performer globally over the last few days and months."

European equity markets rallied Tuesday, with London's FTSE 100 hitting a record 9,911 and the pan-European Stoxx 600 reaching 583.4 points. Safe-haven currencies including the Swiss franc and Japanese yen could gain if equities reverse.

Currency traders are positioning for sustained volatility through mid-2026 as major economies navigate monetary policy transitions alongside fiscal pressures. The dollar's trajectory depends on incoming Fed leadership signals and geopolitical risk premium adjustments across global markets.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com